Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

Abstract : The 1,3-beta- d -glucan (BDG) test is used for the diagnosis of invasive candidiasis (IC) in intensive care units (ICUs). However, its utility for patient management is unclear. This study assessed the impact of BDG test results on therapeutic decisions. This was a single-center observational study conducted in an ICU over two 6-month periods. All BDG test requests for the diagnosis of IC were analyzed. Before the second period, the ICU physicians received a pocket card instruction (algorithm) for targeted BDG testing in high-risk patients.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.univ-lille.fr/hal-03288714
Contributeur : Lilloa Université de Lille Connectez-vous pour contacter le contributeur
Soumis le : vendredi 16 juillet 2021 - 14:09:30
Dernière modification le : vendredi 16 juillet 2021 - 14:09:31

Lien texte intégral

Identifiants

Collections

Citation

Antonios Kritikos, Julien Poissy, Antony Croxatto, Pierre-Yves Bochud, Jean-Luc Pagani, et al.. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis. Journal of clinical microbiology, 2020, Journal of clinical microbiology, 58 (6), ⟨10.1128/jcm.01996-19⟩. ⟨hal-03288714⟩

Partager

Métriques

Consultations de la notice

11